These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus. Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102 [TBL] [Abstract][Full Text] [Related]
5. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. Hanly JG; Robichaud J; Fisk JD J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112 [TBL] [Abstract][Full Text] [Related]
6. Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study. Park DJ; Takahashi Y; Kang JH; Yim YR; Kim JE; Lee JW; Lee KE; Lee JK; Lee SS Clin Exp Rheumatol; 2017; 35 Suppl 105(3):54-60. PubMed ID: 28339361 [TBL] [Abstract][Full Text] [Related]
7. Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor. Chang EH; Volpe BT; Mackay M; Aranow C; Watson P; Kowal C; Storbeck J; Mattis P; Berlin R; Chen H; Mader S; Huerta TS; Huerta PT; Diamond B EBioMedicine; 2015 Jul; 2(7):755-64. PubMed ID: 26286205 [TBL] [Abstract][Full Text] [Related]
8. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus. Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968 [TBL] [Abstract][Full Text] [Related]
9. A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus. Choi MY; FitzPatrick RD; Buhler K; Mahler M; Fritzler MJ Autoimmun Rev; 2020 Mar; 19(3):102463. PubMed ID: 31927088 [TBL] [Abstract][Full Text] [Related]
10. Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus. Szmyrka M; Pokryszko-Dragan A; Słotwiński K; Gruszka E; Korman L; Podemski R; Wiland P Adv Clin Exp Med; 2019 Feb; 28(2):185-192. PubMed ID: 29963787 [TBL] [Abstract][Full Text] [Related]
11. Prevalence, involved domains, and predictor of cognitive dysfunction in systemic lupus erythematosus. Yue R; Gurung I; Long XX; Xian JY; Peng XB Lupus; 2020 Nov; 29(13):1743-1751. PubMed ID: 32938321 [TBL] [Abstract][Full Text] [Related]
12. Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies. Schwarting A; Möckel T; Lütgendorf F; Triantafyllias K; Grella S; Boedecker S; Weinmann A; Meineck M; Sommer C; Schermuly I; Fellgiebel A; Luessi F; Weinmann-Menke J Ann Rheum Dis; 2019 Sep; 78(9):1226-1234. PubMed ID: 31186256 [TBL] [Abstract][Full Text] [Related]
13. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Hanly JG; Urowitz MB; Siannis F; Farewell V; Gordon C; Bae SC; Isenberg D; Dooley MA; Clarke A; Bernatsky S; Gladman D; Fortin PR; Manzi S; Steinsson K; Bruce IN; Ginzler E; Aranow C; Wallace DJ; Ramsey-Goldman R; van Vollenhoven R; Sturfelt G; Nived O; Sanchez-Guerrero J; Alarcón GS; Petri M; Khamashta M; Zoma A; Font J; Kalunian K; Douglas J; Qi Q; Thompson K; Merrill JT; Arthritis Rheum; 2008 Mar; 58(3):843-53. PubMed ID: 18311802 [TBL] [Abstract][Full Text] [Related]
14. The role of anti-ribosomal P autoantibodies in the prediction of neuropsychiatric damage in systemic lupus erythematosus based on CSTAR cohort (XIV). Ding Y; Zhao J; Qian J; Zhang L; Zhang S; Jiang N; Li J; Wu C; Wu Q; Xu D; Leng X; Wang Q; Zhang W; Tian X; Li M; Zeng X Clin Rheumatol; 2022 May; 41(5):1371-1379. PubMed ID: 35083563 [TBL] [Abstract][Full Text] [Related]
15. Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients. Mozo L; López P; Caminal-Montero L; Rodríguez-Carrio J; Suárez A Lupus; 2014 Dec; 23(14):1477-85. PubMed ID: 25107939 [TBL] [Abstract][Full Text] [Related]
16. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus. Ogawa E; Nagai T; Sakuma Y; Arinuma Y; Hirohata S Mod Rheumatol; 2016; 26(3):377-83. PubMed ID: 26429674 [TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India. Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833 [TBL] [Abstract][Full Text] [Related]
19. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Schneebaum AB; Singleton JD; West SG; Blodgett JK; Allen LG; Cheronis JC; Kotzin BL Am J Med; 1991 Jan; 90(1):54-62. PubMed ID: 1986591 [TBL] [Abstract][Full Text] [Related]
20. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India. Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]